fenofibrate has been researched along with Corneal Neovascularization in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Furthermore, fenofibrate suppressed scar formation by reducing type III collagen expression." | 1.46 | Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn. ( Arima, T; Kang, D; Nagasaka, S; Nakano, Y; Shimizu, A; Takahashi, H; Uchiyama, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakano, Y | 2 |
| Arima, T | 2 |
| Tobita, Y | 1 |
| Uchiyama, M | 2 |
| Shimizu, A | 2 |
| Takahashi, H | 2 |
| Nagasaka, S | 1 |
| Kang, D | 1 |
2 other studies available for fenofibrate and Corneal Neovascularization
| Article | Year |
|---|---|
Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
Topics: Animals; Burns, Chemical; Corneal Injuries; Corneal Neovascularization; Cytokines; Disease Models, A | 2020 |
Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn.
Topics: Alkalies; Angiopoietin-1; Angiopoietin-2; Animals; Burns, Chemical; Cicatrix; Collagen Type III; Cor | 2017 |